Clinical Trials Directory

Trials / Completed

CompletedNCT04450134

Histamine H1/H2 Receptors and Training Adaptations

Role of Histamine H1/H2 Receptors in the Health- and Performance-promoting Adaptations to High-intensity Interval Training

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University Ghent · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Exercise training is beneficial for both health and performance. Histamine has been shown to be involved in the acute exercise response. The current study addresses the role of histamine H1/H2 receptor signaling in the chronic training-induced adaptations. Results from this study will yield more insights into the molecular mechanisms of adaptations to exercise training.

Conditions

Interventions

TypeNameDescription
OTHERLactosePlacebo: Lactose capsules
DRUGFexofenadine HydrochlorideH1 receptor antagonist: 540 mg Fexofenadine Hydrochloride
DRUGFamotidineH2 receptor antagonist: 40 mg Famotidine
OTHERHigh-intensity interval training (HIIT)6 weeks HIIT

Timeline

Start date
2019-10-02
Primary completion
2019-12-18
Completion
2021-04-14
First posted
2020-06-29
Last updated
2024-06-07

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04450134. Inclusion in this directory is not an endorsement.